Suicidality in Young Children: Social and Cognitive Developmental Markers of Risk and Resiliency
幼儿自杀:风险和弹性的社会和认知发展标志
基本信息
- 批准号:10449539
- 负责人:
- 金额:$ 17.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-12 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:6 year old7 year oldAddressAdolescentAdultAgeAreaBehaviorBehavioralCessation of lifeChildChildhoodChokingClinicalCognitiveConceptionsDataDepressed moodDevelopmentElectroencephalographyEmotionalEnvironmentEvent-Related PotentialsExhibitsFamily ViolenceFeeling hopelessFeeling suicidalFutureImpairmentInterviewLifeLinkMeasuresMental DepressionMental disordersMentorsMeta-AnalysisMotivationNational Institute of Mental HealthNeurosciencesNursery SchoolsOutcomeP300 Event-Related PotentialsParentsPathway interactionsPlayPreventionProcessPsychopathologyPublic HealthRecording of previous eventsReportingResearchResearch ActivityResearch DesignResearch PriorityRiskRisk FactorsRisk MarkerRoleSchool-Age PopulationScienceSeveritiesSocial FunctioningSpecificityStimulusSuicideSuicide attemptSymptomsTechniquesTrainingTraining ActivityVictimizationViolenceWithdrawalWorkYouthbullyingconflict resolutiondepressive symptomsearly childhoodearly onsetexpectationmodifiable riskmortalitymultidisciplinarynovelnovel strategiesoptimismpeerpeer victimizationpreventive interventionprogramsracial diversityrecruitrelating to nervous systemresilienceresponsesocialsocial culturesocial relationshipssocioeconomicssuicidal behaviorsuicidal risksuicide ratetheoriesviolence exposure
项目摘要
Project Summary
Suicidality in children is a pressing and understudied public health concern. Rates of suicide in youth have tripled
in recent years, yet little is known about the early emergence or development of suicidal ideation and behaviors
(SI/SB). Suicidal ideation (e.g., wishing to be dead, expressing desire to kill oneself) and behaviors (e.g., choking
oneself) have been identified as early as the preschool period in the context of early-onset depression. However,
if and how suicidality presents in non-depressed young children is unknown. Importantly, early suicidality remains
stable into school-age and confers risk for later psychopathology, suggesting lasting impact and continuity of this
early manifestation. Consistent with the NIMH Strategic Objective 2, to “chart mental illness trajectories to
determine when, where, and how to intervene,” the overarching aim of this K01 application is to understand the
developmental contexts in which suicidality emerges in order to identify at-risk youth and to inform preventative
intervention efforts. The proposed study will address a number of questions central to understanding the
development of suicidality in early childhood including how SI/SB is expressed at this early age, the normative
development of the understanding of suicide, if children with SI/SB exhibit lack of optimism and/or pessimism,
and how children with SI/SB process peer acceptance and rejection. A variety of measures, including child
interview and narrative approaches, behavioral tasks, and event related potentials (ERPs) will be administered
to three groups of 4- to 7-year-olds from diverse racial and socioeconomic backgrounds: 1) children with a history
of SI/SB, 2) children with or at risk for psychopathology but no history of SI/SB, and 3) low-risk healthy children.
The inclusion of children with or at risk for psychopathology with no history of SI/SB will address the specificity
of risk factors for suicidality relative to depressive symptoms and other forms of psychopathology. This approach
has the potential to identify transdiagnostic risk-factors of suicidality in young children. The inclusion of low-risk
healthy children will inform our understanding of typical and atypical trajectories of suicide understanding and
provide guidance regarding how and when to address expressions of suicidality in childhood as a clinical
concern. This will be the first study of children this young with SI/SB to be targeted for a study designed to
investigate the developmental antecedents of risk and resilience for SI/SB. Suicide research and prevention is a
high priority research area for NIMH and the described research and training activities will enable the candidate
to develop an independent research program that addresses the rising rates of childhood suicidality. Specifically,
the execution of the proposed project will provide the candidate with training and expertise in suicide research
and prevention, child psychopathology, and ERP techniques. A rich training environment and a multidisciplinary
team of mentors in each of these areas is detailed. Data from this project will be used in a planned R01 to more
deeply investigate racial and/or sociocultural differences in risk factors and developmental trajectories of early-
onset suicidality.
项目概要
儿童自杀是一个紧迫且未被充分研究的公共卫生问题,青少年自杀率增加了两倍。
近年来,人们对自杀意念和行为的早期出现或发展知之甚少
(SI/SB) 自杀意念(例如,希望死、表达自杀的愿望)和行为(例如,窒息)。
早在学龄前时期就已发现早发性抑郁症。
非抑郁儿童是否会出现自杀倾向以及如何出现自杀倾向尚不清楚。重要的是,早期自杀倾向仍然存在。
稳定到学龄并带来以后发生精神病理学的风险,表明这种情况的持久影响和连续性
与 NIMH 战略目标 2 一致,即“绘制精神疾病轨迹
确定何时、何地以及如何进行干预”,该 K01 应用程序的首要目标是了解
自杀出现的发展背景,以识别高危青少年并为预防性预防提供信息
拟议的研究将解决一些对于理解干预至关重要的问题。
儿童早期自杀倾向的发展,包括 SI/SB 在这个早期阶段的表达方式,规范性的
如果患有 SI/SB 的儿童表现出缺乏乐观和/或悲观情绪,则对自杀的理解会发展,
以及患有 SI/SB 的儿童如何处理同伴的接受和拒绝 各种措施,包括儿童。
将管理访谈和叙述方法、行为任务和事件相关电位(ERP)
来自不同种族和社会经济背景的三组 4 至 7 岁儿童:1) 有病史的儿童
SI/SB,2) 患有精神病理学或有精神病理学风险但没有 SI/SB 病史的儿童,以及 3) 低风险健康儿童。
将没有 SI/SB 病史的患有精神病理学或有精神病理学风险的儿童纳入进来将解决特殊性
与抑郁症状和其他形式的精神病理学相关的自杀危险因素。
有潜力识别幼儿自杀的跨诊断危险因素。
健康的儿童将帮助我们了解典型和非典型的自杀轨迹
提供关于如何以及何时将儿童时期自杀倾向的表现作为临床治疗方法的指导
这将是第一项针对这么小的患有 SI/SB 的儿童进行的研究,旨在旨在
调查 SI/SB 的风险和复原力的发展前因是自杀研究和预防的一项工作。
NIMH 的高度优先研究领域以及所描述的研究和培训活动将使候选人能够
具体来说,制定一项独立的研究计划来解决儿童自杀率上升的问题。
拟议项目的执行将为候选人提供自杀研究方面的培训和专业知识
和预防、儿童精神病理学和 ERP 技术。丰富的培训环境和多学科。
每个领域的导师团队都有详细介绍,该项目的数据将用于计划的 R01 至更多内容。
深入调查早期风险因素和发展轨迹的种族和/或社会文化差异
出现自杀倾向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURA HENNEFIELD其他文献
LAURA HENNEFIELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURA HENNEFIELD', 18)}}的其他基金
Suicidality in Young Children: Social and Cognitive Developmental Markers of Risk and Resiliency
幼儿自杀:风险和弹性的社会和认知发展标志
- 批准号:
10609054 - 财政年份:2022
- 资助金额:
$ 17.94万 - 项目类别:
The Development of Optimism in Preschool Age Children: Individual Differences and Implications for Resiliency and Mental Health
学龄前儿童乐观情绪的发展:个体差异及其对心理弹性和心理健康的影响
- 批准号:
9396160 - 财政年份:2017
- 资助金额:
$ 17.94万 - 项目类别:
相似国自然基金
基于代谢组学的蒙古族7-8岁儿童蒙医体质与肠道菌群的相关性研究
- 批准号:81960831
- 批准年份:2019
- 资助金额:35 万元
- 项目类别:地区科学基金项目
基于转录组学技术的蒙古族7-8岁儿童三根体质分类研究
- 批准号:81560739
- 批准年份:2015
- 资助金额:36.0 万元
- 项目类别:地区科学基金项目
7-12岁儿童脊柱颈段数字化三维形态发育研究
- 批准号:81260269
- 批准年份:2012
- 资助金额:52.0 万元
- 项目类别:地区科学基金项目
相似海外基金
CRCNS: Dense longitudinal neuroimaging to evaluate learning in childhood
CRCNS:密集纵向神经影像评估儿童学习情况
- 批准号:
10835136 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Suicidality in Young Children: Social and Cognitive Developmental Markers of Risk and Resiliency
幼儿自杀:风险和弹性的社会和认知发展标志
- 批准号:
10609054 - 财政年份:2022
- 资助金额:
$ 17.94万 - 项目类别:
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
- 批准号:
10480649 - 财政年份:2022
- 资助金额:
$ 17.94万 - 项目类别:
Neurally targeted group intervention to reduce early childhood anxiety
神经靶向群体干预减少儿童早期焦虑
- 批准号:
10544492 - 财政年份:2022
- 资助金额:
$ 17.94万 - 项目类别:
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
- 批准号:
10616658 - 财政年份:2022
- 资助金额:
$ 17.94万 - 项目类别: